Blood Transfusion Diagnostics Market Players:
- Immucor, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Quotient Limited
- Beckman Coulter, Inc.
- DiaSorin S.p.A.
- BD (Becton, Dickinson, and Company)
- Ortho Clinical Diagnostics
- Grifols, S.A.
- Thermo Fisher Scientific Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of blood transfusion diagnostics is evaluated at USD 5.64 Billion.
The global blood transfusion diagnostics market size was worth more than USD 5.35 Billion in 2025 and is poised to witness a CAGR of over 6.1%, crossing USD 9.67 Billion revenue by 2035.
The North America blood transfusion diagnostics market will hold over 41% share by 2035, attributed to high accident rates and COVID-19 related blood supply disruptions.
Key players in the market include Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc.
